Foresight Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $316.25M
IPO Date Feb 10, 2021
CEO Michael Balkin
Left Lead Cowen
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Consumer

Technology-enabled consumer or consumer healthcare

IPO Geography Global
Target Company P3 Health Partners
Deal Announced May 25, 2021
Deal Size, $M $2,336.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Dec 3, 2021
Amendment Vote TBD
Closing Date Dec 3, 2021
Formerly FORE PIII PIIIW

Sign up for Free Trial

No credit card required

Sign in for more on Foresight Acquisition Corp.:

  • Structure and cap table
  • 11 directors & officers
  • 25 filings and events
  • 1 underwriters
  • 6 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Greg Wasson 62 Chairman
Michael Balkin 61 CEO and Director
Gerald Muizelaar 46 CFO
Brian Gamache 62 Director
Robert Zimmerman 69 Director
John Svoboda 63 Director
Mark Thierer Advisor
Kermit Crawford Advisor
Matt Shattock Advisor
Theodore Koenig Advisor
Craig Zummer Advisor

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Cowen BR 27,500,000 units
27,500,000 units
Up-Front UW fee 2.00 %
BCMA 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 25 filings.

Shareholders

Sign in to view shareholders 13F filing data.